Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions

J A Cossins1, J M Clements, J Ford

  • 1British Biotech Pharmaceuticals, Oxford, UK.

Acta Neuropathologica
|January 28, 1998
PubMed

Insights

Matrix metalloproteinases (MMPs), specifically MMP-7 and MMP-9, are upregulated in active multiple sclerosis (MS) lesions. Their presence in macrophages and blood vessels suggests a role in MS pathology and blood-brain barrier breakdown.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) involves blood-brain barrier breakdown and immune cell infiltration into the central nervous system (CNS).
  • Myelin degradation by macrophages is a hallmark of MS lesions.
  • Proteinases, including matrix metalloproteinases (MMPs), may play a role in MS pathogenesis.

Purpose of the Study:

  • To investigate the cellular localization and distribution of MMP-7 (matrilysin) and MMP-9 (92-kDa gelatinase) in normal human CNS and active demyelinating MS lesions.
  • To determine if MMPs are specifically induced in MS lesions.

Main Methods:

  • Immunohistochemistry was used to detect MMP-7 and MMP-9 protein expression in CNS tissue sections.
  • Non-radioactive in situ hybridization (ISH) was performed to confirm MMP-7 gene expression.
  • Tonsil and spleen tissues were used as controls for macrophage MMP-7 expression.

Main Results:

  • MMP-7 immunoreactivity was weak in normal CNS microglial cells but strong in macrophages within active MS lesions.
  • MMP-7 expression in macrophages was confirmed by ISH and found to be specific to MS lesions.
  • MMP-9 immunoreactivity was observed in blood vessels, with increased staining in MS lesions compared to normal CNS.

Conclusions:

  • MMP-7 is specifically induced in macrophages infiltrating active demyelinating MS lesions.
  • MMP-9 is upregulated in blood vessels within MS lesions.
  • The upregulation of MMPs in MS suggests they contribute to the disease's pathology, potentially through blood-brain barrier disruption and tissue degradation.